Related Experiment Videos
Reduction of risk to patients through optimized planning of clinical drug development
1Pharmaceutical Research Center, Baver AG, Wuppertal, Fed. Rep. of Germany.
Arzneimittel-Forschung
|August 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
PA21: a novel phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease.
Clinical nephrology·2010
[Retrospective analysis of tuberculosis caused by Mycobacterium bovis 2004 - 2008].
Pneumologie (Stuttgart, Germany)·2010
Is the umbo matrix of bivalve shells (Laternula elliptica) a climate archive?
Aquatic toxicology (Amsterdam, Netherlands)·2007
[Pulmonary nocardiosis with trimethoprime/sulphamethoxazole-resistant Nocardia paucivorans in a patient with no signs of immunosuppression].
Pneumologie (Stuttgart, Germany)·2007
Determination of the electron self-exchange rates of blue copper proteins by super-WEFT NMR spectroscopy.
Journal of biomolecular NMR·2001
Leave-one-out procedure in the validation of elimination rate constant analysis.
Arzneimittel-Forschung·2012
Fluorescence detection of etoposide-loaded nanoparticles by HPLC and pharmacokinetics study.
Arzneimittel-Forschung·2012
Model-based clinical pharmacology profiling of subcutaneous nivolumab in renal cell carcinoma: Bridging to alternative dosing regimens and indications.
Clinical pharmacology and therapeutics·2026
Targeting Serotonin 5-HT2A Receptors in the Treatment of Aggression: from Antipsychotics to Psychedelics.
Aggression and violent behavior·2026
Where do people obtain side effect information? Results from a census-matched U.S. national survey.
Exploratory research in clinical and social pharmacy·2026